Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Hematology/Oncology Clinics of North America|September 1, 1988
Treating malignancies with curative intent: understanding growth and differentiationB W DanaCancer Clinical Trials|January 1, 1981
Combination chemoimmunotherapy for advanced renal carcinoma with Adriamycin, bleomycin, vincristine, cyclophosphamide, plus BCGB W Dana, D S AlbertsAmerican Journal of Clinical Oncology|October 1, 1985
Dexamethasone vs. placebo for cisplatin-induced emesis. A randomized cross-over trialB W Dana, E C Everts, D DickinsonAmerican Journal of Clinical Oncology|June 1, 1987
A randomized trial of high dose bolus metoclopramide versus low-dose continuous infusion metoclopramide in the prevention of cisplatin-induced emesisB W Dana, M McDermott, E Everts, et al.Cancer Treatment Reports|February 1, 1986
Salvage treatment of unfavorable non-Hodgkin's lymphoma with cisplatin, amsacrine, and mitoguazone: a Southwest Oncology Group Pilot StudyB W Dana, S E Jones, C Coltman, et al.Blood|January 1, 1981
Concomitant administration of granulocyte transfusions and amphotericin B in neutropenic patients: absence of significant pulmonary toxicityB W Dana, B G Durie, R F White, et al.The Journal of Urology|March 1, 1995
Primary penile lymphoma presenting as a penile ulcerC A Fairfax, C J Hammer, B W Dana, et al.Cancer Research|October 1, 1986
Methylthioadenosine phosphorylase deficiency in human leukemias and solid tumorsJ H Fitchen, M K Riscoe, B W Dana, et al.Seminars in Hematology|April 1, 1987
Southwest oncology group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomasR I Fisher, T P Miller, B W Dana, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapyB W Dana, S Dahlberg, B N Nathwani, et al.Pageof 2